An important nation wide study published in JAMA that evaluated the overlap of Autism and ADHD in American adults.

Autistic adults were found to have high rates of co-occurring ADHD and negative health outcomes such as cardiovascular disease and injury were significantly higher in those with combined Autism and ADHD. Of note, treating ADHD appeared to improve overall health outcomes in this population.

Read article: https://apsard.org/wp-content/uploads/2025/02/Autism-ADHD-Adults-JAMA.pdf 

As a follow up to his ADHD 201 at the APSARD Annual Conference on comorbidities, APSARD President interviewed on CNBC for a breakthrough depression indication. 

Read article:  https://www.cnbc.com/2025/01/21/fda-approves-johnson-johnson-nasal-spray-spravato-for-depression.html 

The largest meta-analysis of 2,472 ADHD patients from 38 randomized controlled trials of neuro feedback was just published in JAMA. Unfortunately, the overall data “did not appear to meaningfully benefit with neurofeedback in individuals with ADHD, clinically or neuropsychologically, at the group level.”

A total of 38 RCTs (2472 participants aged 5 to 40 years) were included.

Read article: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2827733 

With an aging population and under recognition of ADHD in older adults, we are missing the opportunity to effectively treat these individuals.

Read article: https://www.nytimes.com/2024/12/11/well/mind/adhd-diagnosis-older-middle-age.html?smid=nytcore-android-share